For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Expanding Cell Therapy Clinical Trials to Community Health Centers: Training Healthcare Providers
Wednesday, May 29, 2024 10:45 AM - 11:45 AM  
Room 201
Workforce Development
Roundtable
Organized by: ISCT Clinical Translation Committee

Moderator
  • Kim Watanabe, PhD, PPD, part of Thermo Fisher Scientific, United States
Panelists
  • Emily Blyth, B.Med (Hons) FRACP, FRCPA, PhD, Westmead Hospital, University of Sydney, Westmead Institute For MedicalAustralia
  • Michelle Hermiston, MD, PhD, UCSF, United States
  • Shirley Bartido, PhD, MBA, Takeda Development Center Americas, Inc., United States
Address how training programs can enable cell therapy clinical trials outside large established hospitals, despite knowledge gaps and key financial, facility, regulatory, and personnel challenges.

Key Learning Objectives
1. Awareness of current challenges
2. Practical solutions required to enable inexperienced clinical sites to partake in cell therapy clinical trials and administer commercialized products
3. Preparing for CAR-T therapies in becoming SOC 
Kim Watanabe
Executive Director, Cell and Gene Therapy Pillar Head
 PPD, Part of Thermo Fisher Scientific
 Moderator
Emily Blyth
Lead, Immune effector Cell Service
 Westmead Hospital
 Panelist
Michelle Hermiston
Professor
 University of California San Francisco
 Panelist
Shirley Bartido
Director, Global Regulatory Affairs Cell Therapy Oncology
 Takeda Pharmaceuticals Company Limited
 Panelist